The STOP/Contre‑Feu narrative and the Tobacco Tactics profile both emphasise that some on the GINN Leadership Team previously worked for or with multinational tobacco companies and then infer a present‑day link or alignment with those firms’ lobbying objectives. That move is a textbook guilt‑by‑association tactic: past disclosed employment or sector experience is presented as sufficient to…
In 2023, Canada approved a tobacco-free oral nicotine pouch, marketed under the name Zonnic, as a nicotine replacement therapy for adult smokers. However, the regulatory framework governing its sale and distribution has created an unexpected contradiction: in some circumstances, it is now more difficult for adult smokers to obtain these potentially lower-risk products than to…
Public understanding of nicotine products increasingly depends on how science is communicated through mainstream media. Yet, misinformation and oversimplified reporting continue to influence how adults who smoke, regulators, and health professionals interpret the risks of non-combustible nicotine products. These narratives often emerge not from a lack of scientific evidence, but from how research is framed,…
COP11 has concluded, but the debate around nicotine regulation is far from settled. While delegates left Geneva without adopting aggressive new restrictions, the WHO’s long-standing hostility toward tobacco harm reduction remains firmly in place. The organization continues to frame non-combustible products, such as nicotine pouches, e-cigarettes, and heated tobacco, through the same lens as conventional…
I’m delighted to welcome María del Carmen Ordóñez López as GINN’s Legal Advisor. María del Carmen brings more than two decades of strategic legal, compliance and governance experience across multinational corporations, start-ups and specialist advisory roles, and will be a pivotal voice in shaping our legal and regulatory work on novel nicotine policy and harm-reduction…
Saudi Arabia’s successful Public Health experiment Backed by the Public Investment Fund (PIF), Saudi company Badael has rapidly scaled its harm reduction initiative using its flagship DZRT tobacco-free nicotine pouch. Since its 2023 launch, the program has helped nearly 400,000 smokers move away from combustible tobacco, with 140,000 reportedly quitting nicotine altogether. This progress contributes…
A recent study published in JAMA Network Open provides important insights into the biological effects of nicotine pouches, adding much-needed clinical evidence to an area often dominated by speculation. The findings reaffirm a central message in tobacco harm reduction: while nicotine is addictive, the health risks associated with non-combustible nicotine products are dramatically lower than…
What a night! Great conversations, new connections, and plenty of collaboration with colleagues from across the nicotine pouch sector. 🗓️ 6:30–9:30 PM, Fri 14 November 📍 Central Stockholm We can’t wait to welcome you — come along, meet the community, and be part of the conversation. Want to join us? Drop us a line at…
Nicotine has been vilified for decades, often conflated with the devastating health effects of smoking. Yet modern medical research continues to show that nicotine itself is not the cause of smoking-related cancers or cardiovascular disease. Instead, it is the combustion of tobacco, the burning process that releases thousands of toxic chemicals, that drives most smoking-related…
Momentum is building in the United Kingdom toward a coherent and proportionate framework for regulating tobacco-free nicotine pouches. The Tobacco and Vapes Bill, currently progressing through Parliament, and the surrounding debates in both Houses have positioned the UK to establish a model that balances youth protection with adult harm reduction, consistent with NHS guidance and…